187660 ADM Korea Share Price

0.000.00%
kr flag iconLast Trade - 00:00
HealthcareHighly SpeculativeSmall CapFalling Star

Momentum

Relative strength (%)
1m-22.81%
3m
6m
1yr
Volume change (%)
10d/3m
Price vs... (%)
52w High-48.18%
50d MA
200d MA

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Financial Summary

Year End 31st DecUnit201620172018201920202021E2022ECAGR / Avg
Total RevenueKR₩mn/an/a2,388.910,206.0913,120.16n/an/a134.35%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%n/an/an/a+57.79+392.62n/an/an/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecast

Price target
( price)
31st Dec 202131st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2021 / 2022

Blurred out image of ADM Korea EPS forecast chart

Profile Summary

ADM Korea Inc is a Korea-based company primarily engaged in the provision of clinical trial services. The Company is a contract research organization (CRO) that provides clinical trial related services to pharmaceutical companies and bio ventures. The Company also provides post-marketing research (rPMS) services.

Directors

    Last Annual
    December 31st, 2020
    Last Interim
    January 1st, 1970
    Incorporated
    October 31st, 2003
    Public Since
    June 3rd, 2021
    Sector
    Biotechnology & Medical Research
    Industry
    Healthcare
    Exchange
    kr flag iconKorea Exchange - KOSDAQ
    Shares in Issue
    21,836,250
    Blurred out image of a map
    Address
    711, SEOUL, 03173
    Web
    http://www.admkorea.co.kr/
    Phone
    +82 27301457
    Auditors
    LIAN Accounting Corporation

    187660 Share Price Performance

    Similar to 187660

    Picture of APTAMER SCIENCES ORD logo

    APTAMER SCIENCES ORD

    kr flag iconKorea Exchange - KOSDAQ

    Picture of BIOTOXTECH ORD logo

    BIOTOXTECH ORD

    kr flag iconKorea Exchange - KOSDAQ

    CELEMICS ORD

    kr flag iconKorea Exchange - KOSDAQ

    Picture of CHA BIOTECH ORD logo

    CHA BIOTECH ORD

    kr flag iconKorea Exchange - KOSDAQ

    Picture of CHEMON ORD logo

    CHEMON ORD

    kr flag iconKorea Exchange - KOSDAQ

    FAQ